-
A23187, free acid: Calcium Ionophore Workflows
2026-09-16
A23187, free acid provides a controllable way to elevate intracellular Ca2+ and connect calcium signaling with phosphoinositide metabolism, ROS generation, and cell death. This guide pairs practical ionophore workflows with a response-analysis framework that separates growth inhibition from true killing.
-
Metastatic Evolution and CRC Therapeutic Heterogeneity
2026-09-15
Cho and colleagues used patient-derived xenografts and multi-omic profiling to show that colorectal cancer metastasis can reshape subclonal architecture, gene expression, and DNA methylation in clinically relevant ways. The study links these dynamic changes to in vivo therapeutic heterogeneity, supporting matched, evolution-aware designs for colon cancer research.
-
MPC-Lactate Signaling and Dendritic-Cell Lactylation
2026-09-15
The 2025 reference study identifies mitochondrial pyruvate carrier (MPC) loss as a driver of lactate accumulation, histone lactylation, dendritic-cell dysregulation, and impaired CD8+ T-cell activity in colorectal cancer. Its experiments connect tumor metabolism with immune regulation and show that increasing MPC activity can improve anti-PD-1 responses, while also defining important limits for translating this mechanism to other disease areas.
-
Selective ClpP Activation in Lung Squamous Cell Carcinoma
2026-09-14
The reference study identifies ZK53 as a selective activator of human mitochondrial ClpP and explains how mitochondrial proteostasis disruption suppresses lung squamous cell carcinoma. By linking ClpP-dependent respiratory failure to E2F-associated transcriptional changes, ATM-mediated DNA damage signaling, and cell-cycle arrest, the work provides a mechanistic framework for mitochondrial-targeted cancer research.
-
12-O-tetradecanoyl phorbol-13-acetate (TPA)
2026-09-14
This scenario-driven guide explains how 12-O-tetradecanoyl phorbol-13-acetate (TPA), SKU N2060, can improve the design and interpretation of PKC, ERK/MAPK, viability, and cytotoxicity experiments. It links formulation, stock handling, time-resolved sampling, orthogonal readouts, and vendor-selection decisions to practical laboratory reliability.
-
Dual-Network Microgels for Intervertebral Disc Degeneration
2026-09-13
The reference study develops POCM@MCCP, an elastic dual-network hydrogel microsphere that combines sustained miR-155 delivery with EGCG- and strontium-based modulation of the inflammatory disc microenvironment. Its stimulus-responsive release design suppressed inflammation, reduced apoptosis-associated signaling, limited oxidative stress, and improved nucleus pulposus cell function in in vitro and in vivo models of intervertebral disc degeneration.
-
Fluorescein TSA Fluorescence System Kit Workflow
2026-09-12
Translate astrocyte atlas discoveries into spatially resolved protein and RNA validation with sensitive tyramide deposition. This workflow shows how to adapt the Fluorescein TSA Fluorescence System Kit for developmental brain tissue, cultured cells, and low-abundance targets while controlling background and saturation.
-
Sodium Oxamate: LDH-A Workflow for TNBC
2026-09-11
Sodium Oxamate provides an aqueous, vehicle-controlled way to suppress LDH-A-linked lactate production and test metabolic dependencies in cancer cells. This workflow connects lactate measurements with apoptosis, histone lactylation, and SLFN5 assays, translating a TNBC study into practical experimental decisions.
-
Nebivolol: A Precision Tool for β1 Signaling
2026-09-11
Nebivolol hydrochloride is more than a selective β1 blocker: it is a strategic probe for separating receptor-driven cardiovascular phenotypes from broader pathway effects. This article connects β1-adrenoceptor pharmacology with drug-sensitized yeast evidence, practical assay design, translational positioning, and a disciplined interpretation of negative mTOR findings.
-
12-O-tetradecanoyl phorbol-13-acetate Workflows
2026-09-10
Build reproducible PKC and ERK/MAPK pathway activation assays with TPA, from rapid phospho-signaling measurements to skin cancer model design. The workflow also shows how to use TPA as a pathway-competence control when interpreting ICOS-driven T-cell experiments without confusing broad PKC activation with antigen-specific biology.
-
H-89 for PKA and cAMP Signaling Assays
2026-09-10
H-89 provides a rapid pharmacological route to test PKA involvement in cAMP signaling, Wnt-driven osteoblast metabolism, proliferation, and apoptosis assays. Its greatest value comes from pairing dose and timing matrices with orthogonal pathway controls rather than treating one inhibitor concentration as definitive proof of mechanism.
-
Stiripentol: LDH, Lactate, and Assay Design
2026-09-09
Stiripentol is a chemically distinct LDH inhibitor for studying lactate flux, neuronal excitability, and Dravet syndrome treatment research. This article connects astrocyte-neuron lactate shuttle modulation with histone lactylation findings and translates them into practical assay decisions.
-
Phenytoin for Dynamic Myelin Damage Assays
2026-09-09
Phenytoin provides a controllable sodium-channel activity perturbation for linking neuronal firing to early, potentially reversible myelin swelling. This workflow pairs concentration-controlled dosing with live imaging and electrophysiology rather than relying only on endpoint demyelination measurements.
-
Rottlerin: From PKCδ Mechanism to Translation
2026-09-08
Rottlerin is more than a PKC inhibitor for endpoint-driven assays: it can help translational researchers connect PKCδ signaling with proliferation, apoptosis, endothelial barrier biology, and host–pathogen entry. This thought-leadership perspective outlines how to use Rottlerin rigorously, interpret its selectivity, and extend findings across disease models without overstating preclinical evidence.
-
Vacuolin-1 Workflows for Lysosomal Exocytosis
2026-09-08
Vacuolin-1 provides a selective way to dissect Ca2+-dependent lysosomal exocytosis without broadly suppressing membrane trafficking. This guide connects practical cell-based assays with disease-model questions involving membrane repair, protease release, and growth factor signaling.